is mounjaro a glp-1 medicine Eli Lilly launches weight loss drug in India at Rs 3,500 per 2.5mg dose GLP-1 Drug Prescriptions Have Doubled

That's significant because it encourages health insurance providers to support these treatments

Something about the newer, more potent formulations, or perhaps the degree of weight loss they produce, drives the risk higher

Dont Have Diabetes Diagnosis The Problem: Mounjaro only covered for type 2 diabetes Want tirzepatide for weight loss only Dont qualify for Mounjaro coverage Zepbound not covered either The Solution: Alternatives dont require diabetes diagnosis and focus on weight loss indication

FDA AI Guidance 2026: Drug Manufacturing & Digital Health Analyze the FDA CDER 2026 guidance pipeline for artificial intelligence in drug manufacturing and digital health technologies in pharmaceutical development

What are the differences between different types of weight loss medications